The metabolism of Rosuvastatin can be decreased when combined with Rucaparib. The risk or severity of adverse effects can be increased when Amrinone is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Lapatinib. The serum concentration of Rosuvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The serum concentration of Rosuvastatin can be increased when it is combined with Arsenic trioxide. The serum concentration of Rosuvastatin can be increased when it is combined with Prednisolone. The metabolism of Rosuvastatin can be increased when combined with Primidone. The serum concentration of Rosuvastatin can be decreased when it is combined with Aluminum hydroxide. The serum concentration of Rosuvastatin can be increased when it is combined with Cocaine. The serum concentration of Rosuvastatin can be increased when it is combined with Osimertinib. The serum concentration of Rosuvastatin can be decreased when it is combined with Almasilate. The serum concentration of Rosuvastatin can be increased when it is combined with Acetazolamide. The serum concentration of Rosuvastatin can be increased when it is combined with Epigallocatechin Gallate. The serum concentration of Ubidecarenone can be increased when it is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Ziprasidone. The serum concentration of Rosuvastatin can be increased when it is combined with Nitric Oxide. The serum concentration of Rosuvastatin can be increased when it is combined with Vinorelbine. The serum concentration of Rosuvastatin can be increased when it is combined with Nifedipine. The risk or severity of adverse effects can be increased when Ravuconazole is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Isradipine. The serum concentration of Rosuvastatin can be increased when it is combined with Clotiazepam. The serum concentration of Rosuvastatin can be increased when it is combined with Benzamidine. The serum concentration of Rosuvastatin can be increased when it is combined with Ergonovine. The serum concentration of Rosuvastatin can be increased when it is combined with Lisinopril. The serum concentration of Rosuvastatin can be increased when it is combined with Astemizole. The metabolism of Rosuvastatin can be increased when combined with Carbamazepine. The serum concentration of Rosuvastatin can be increased when it is combined with Haloperidol. The serum concentration of Rosuvastatin can be increased when it is combined with Ezetimibe. The serum concentration of Rosuvastatin can be increased when it is combined with Mefloquine. The serum concentration of Rosuvastatin can be increased when it is combined with Miconazole. The metabolism of Rosuvastatin can be decreased when combined with Olaparib. The serum concentration of Rosuvastatin can be increased when it is combined with Cilostazol. The risk or severity of adverse effects can be increased when Azelnidipine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Phosphoramidon. The serum concentration of Rosuvastatin can be increased when it is combined with Buprenorphine. The risk or severity of adverse effects can be increased when Ziconotide is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Midostaurin. The metabolism of Rosuvastatin can be decreased when combined with Floxuridine. The serum concentration of Rosuvastatin can be increased when it is combined with Primaquine. The serum concentration of Rosuvastatin can be increased when it is combined with Clofazimine. The serum concentration of Rosuvastatin can be increased when it is combined with Letaxaban. The serum concentration of Rosuvastatin can be increased when it is combined with Lopinavir. The risk or severity of adverse effects can be increased when Fendiline is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Citalopram. The metabolism of Rosuvastatin can be decreased when combined with Manidipine. The serum concentration of Rosuvastatin can be increased when it is combined with Oxymetholone. The serum concentration of Rosuvastatin can be increased when it is combined with Nelfinavir. The metabolism of Rosuvastatin can be decreased when combined with Fluorouracil. The serum concentration of Mevastatin can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium Hydroxide. The serum concentration of Rosuvastatin can be increased when it is combined with Quinapril. The serum concentration of Rosuvastatin can be increased when it is combined with Boceprevir. The metabolism of Rosuvastatin can be decreased when combined with Atomoxetine. The serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium Trisilicate. The metabolism of Rosuvastatin can be decreased when combined with Modafinil. The serum concentration of Rosuvastatin can be increased when it is combined with Ledipasvir. Acipimox may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Isavuconazonium. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Levosalbutamol. The serum concentration of Rosuvastatin can be increased when it is combined with Thiorphan. The serum concentration of Rosuvastatin can be increased when it is combined with Quinupristin. The risk or severity of adverse effects can be increased when Gabapentin is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Pantoprazole. The risk or severity of adverse effects can be increased when Metergoline is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Niludipine is combined with Rosuvastatin. The metabolism of Rosuvastatin can be decreased when combined with Fluvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Methylergometrine. The metabolism of Rosuvastatin can be decreased when combined with Omeprazole. The serum concentration of Rosuvastatin can be increased when it is combined with Progesterone. The serum concentration of Rosuvastatin can be increased when it is combined with Mirtazapine. The serum concentration of Rosuvastatin can be increased when it is combined with Dronedarone. The metabolism of Rosuvastatin can be decreased when combined with Losartan. The serum concentration of Ibrutinib can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Spirapril. The serum concentration of Rosuvastatin can be increased when it is combined with Desipramine. The serum concentration of Rosuvastatin can be increased when it is combined with Ximelagatran. The serum concentration of Rosuvastatin can be increased when it is combined with Tramadol. The serum concentration of Rosuvastatin can be increased when it is combined with Cyproterone acetate. The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be decreased when it is combined with Aluminium. The serum concentration of Rosuvastatin can be increased when it is combined with Batimastat. The serum concentration of Rosuvastatin can be increased when it is combined with 1,10-Phenanthroline. The serum concentration of Rosuvastatin can be decreased when it is combined with Vemurafenib. The serum concentration of Rosuvastatin can be increased when it is combined with Dasabuvir. The serum concentration of Rosuvastatin can be increased when it is combined with Sirolimus. The metabolism of Rosuvastatin can be increased when combined with Secobarbital. The serum concentration of Rosuvastatin can be increased when it is combined with Mibefradil. The serum concentration of Rosuvastatin can be increased when it is combined with Paramethasone. The serum concentration of Rosuvastatin can be increased when it is combined with Capsaicin. The serum concentration of Rosuvastatin can be increased when it is combined with Indinavir. The risk or severity of adverse effects can be increased when Solithromycin is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Mequitazine. The serum concentration of Rosuvastatin can be increased when it is combined with Etoricoxib. The serum concentration of Rosuvastatin can be increased when it is combined with Troleandomycin. The metabolism of Rosuvastatin can be decreased when combined with Topiroxostat. The metabolism of Rosuvastatin can be increased when combined with Bosentan. The serum concentration of Rosuvastatin can be increased when it is combined with Cilazapril. The risk or severity of adverse effects can be increased when Nicotinamide is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Gabexate. The serum concentration of Rosuvastatin can be increased when it is combined with Dasatinib. The risk or severity of adverse effects can be increased when Prenylamine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Prednisone. The serum concentration of Rosuvastatin can be increased when it is combined with Cisapride. The serum concentration of Rosuvastatin can be increased when it is combined with Norfloxacin. Rosuvastatin may increase the hepatotoxic activities of Pazopanib. The serum concentration of Bosutinib can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Itraconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Candoxatril. The metabolism of Rosuvastatin can be decreased when combined with Sulfadiazine. The serum concentration of Rosuvastatin can be decreased when it is combined with Eslicarbazepine acetate. The serum concentration of Rosuvastatin can be increased when it is combined with Fosinopril. The metabolism of Rosuvastatin can be decreased when combined with Doxycycline. Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Pilocarpine. The serum concentration of Rosuvastatin can be increased when it is combined with Darunavir. The serum concentration of Rosuvastatin can be increased when it is combined with Pergolide. The serum concentration of Rosuvastatin can be increased when it is combined with Rabeprazole. The metabolism of Rosuvastatin can be decreased when combined with Capecitabine. The serum concentration of Rosuvastatin can be increased when it is combined with Azelastine. The serum concentration of Rosuvastatin can be increased when it is combined with Lomustine. The serum concentration of Rosuvastatin can be increased when it is combined with Dalfopristin. Bezafibrate may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Econazole. The serum concentration of Rosuvastatin can be increased when it is combined with Terfenadine. The metabolism of Rosuvastatin can be decreased when combined with Crizotinib. The metabolism of Rosuvastatin can be decreased when combined with Moclobemide. The serum concentration of Rosuvastatin can be increased when it is combined with Fosamprenavir. The risk or severity of adverse effects can be increased when Oxiconazole is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Etoposide.